Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Director Dealing & Total Voting Rights

20 Apr 2015 07:00

RNS Number : 6313K
Ideagen PLC
20 April 2015
 

Ideagen plc

 

("Ideagen" or the "Company")

 

Exercise of Options, Director Dealing & Total Voting Rights 

 

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that it has applied for the admission to trading on AIM of a total of 1,918,080 new ordinary shares of 1p each ("Ordinary Shares") issued following an exercise (the "Exercise") of options over Ordinary Shares by directors (the "Directors") of the Company on 17 April 2015.

 

These new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares and admission is expected to be effective on 23 April 2015 (the "Admission").

 

Directors' Dealings

 

Following the Exercise, and on the same day, the Directors subsequently sold a total of 1,918,080 of these new Ordinary Shares, each at a price of 35 pence per Ordinary Share (the "Sale"), principally to fund the income tax and national insurance liabilities arising on the Exercise, as set out below.

 

Name of Director

New Ordinary Shares issued pursuant to the Exercise

Number of Ordinary Shares sold pursuant to the Sale

New holding of Ordinary Shares

New interest as a percentage of the Company's issued share capital

David Hornsby

2,800,000

1,780,800

9,404,033

5.30%

Graeme Spenceley

200,000

137,280

62,720

0.04%

Total

3,000,000

1,918,080

9,466,753

5.34%

 

 

Total Voting Rights

 

The Company advises that, following the issue of the new Ordinary Shares pursuant to the Exercise as set out above, the total number of Ordinary Shares in issue will be 177,341,678 and the total number of voting rights will therefore be 177,341,678. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules. 

 

 

 

Enquiries:

Ideagen Plc

Tel: 01629 699100

David Hornsby, Chief Executive

Graeme Spenceley, Finance Director

finnCap (Nominated Adviser and Broker)

Tel: 020 7220 0500

Stuart Andrews / James Thompson (Corporate Finance)

Stephen Norcross

(Corporate Broking)

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKLXFEKSEFF
Date   Source Headline
1st Jul 202211:27 amRNSForm 8.5 (EPT/RI)
30th Jun 20223:20 pmRNSForm 8.3 - Ideagen plc
30th Jun 20221:38 pmRNSForm 8.3 -IDEAGEN PLC
30th Jun 202211:03 amGNWForm 8.3 - Ideagen PLC
30th Jun 20229:57 amRNSForm 8.5 (EPT/RI)
29th Jun 20224:00 pmRNSHolding(s) in Company
29th Jun 20223:30 pmRNSForm 8.3 - Ideagen Plc
29th Jun 20223:30 pmRNSForm 8.3 - IDEA LN
29th Jun 20223:30 pmGNWForm 8.3 - Ideagen plc
29th Jun 20223:20 pmRNSForm 8.3 - Ideagen plc
29th Jun 20222:04 pmRNSForm 8.3 - Ideagen plc
29th Jun 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
29th Jun 202211:48 amRNSForm 8.5 (EPT/RI)
29th Jun 20227:00 amRNSHolding(s) in Company
28th Jun 20223:30 pmRNSForm 8.3 - IDEA LN
28th Jun 20223:11 pmBUSForm 8.3 - Ideagen Plc
28th Jun 20223:00 pmRNSForm 8.3 - Ideagen PLC
28th Jun 202212:37 pmGNWForm 8.3 - [Ideagen plc - 28 06 2022] - (CGWL)
28th Jun 202212:20 pmRNSForm 8.3 - Ideagen plc
28th Jun 202210:00 amRNSHolding(s) in Company
27th Jun 20223:29 pmRNSForm 8.3 - Ideagen plc
27th Jun 20223:20 pmRNSForm 8.3 - Ideagen plc
27th Jun 20222:45 pmRNSForm 8.3 - Ideagen PLC
27th Jun 202212:53 pmRNSForm 8.3 - Ideagen plc
27th Jun 202211:28 amRNSForm 8.5 (EPT/RI)
27th Jun 202211:10 amRNSForm 8.3 - IDEAGEN PLC
24th Jun 20225:03 pmRNSForm 8.3 - Ideagen plc Amendment
24th Jun 20223:30 pmBUSForm 8.3 - Ideagen plc
24th Jun 20223:30 pmGNWForm 8.3 - Ideagen plc
24th Jun 20223:03 pmRNSForm 8.3 - Ideagen Plc
24th Jun 20223:00 pmRNSForm 8.3 - Ideagen Plc
24th Jun 20221:19 pmRNSForm 8.3 - Ideagen plc
24th Jun 20221:06 pmRNSForm 8.3 - Ideagen Plc
24th Jun 202211:24 amRNSForm 8.5 (EPT/RI)
24th Jun 202210:10 amRNSForm 8.5 (EPT/RI)
24th Jun 20228:17 amRNSForm 8.5 (EPT/RI) - Amendment
23rd Jun 20226:35 pmRNSResults of Court Meeting and General Meeting
23rd Jun 20223:32 pmRNSForm 8.3 - Ideagen Plc
23rd Jun 20223:30 pmBUSForm 8.3 - Ideagen plc
23rd Jun 20223:30 pmGNWForm 8.3 - Ideagen plc
23rd Jun 20223:20 pmRNSForm 8.3 - Ideagen plc
23rd Jun 20223:16 pmRNSForm 8.3 - IDEAGEN PLC - AMENDMENT
23rd Jun 20222:45 pmRNSForm 8.3 - Ideagen PLC
23rd Jun 20222:30 pmRNSHolding(s) in Company
23rd Jun 20221:16 pmGNWForm 8.3 - Ideagen PLC
23rd Jun 202211:54 amRNSForm 8.3 - IDEAGEN PLC
23rd Jun 202211:41 amRNSForm 8.3 - Ideagen plc
23rd Jun 202211:21 amRNSForm 8.5 (EPT/RI)
23rd Jun 20228:42 amRNSForm 8.5 (EPT/RI)
22nd Jun 20225:59 pmRNSForm 8.3 - IDEA LN

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.